Literature DB >> 17376006

Magnetic resonance imaging-monitored plasmid DNA delivery in primate limb muscle.

Karl K Vigen1, Julia O Hegge, Guofeng Zhang, Rajat Mukherjee, Serge Braun, Thomas M Grist, Jon A Wolff.   

Abstract

The purpose of this work is to investigate the use of magnetic resonance imaging (MRI) to monitor the effects of high-pressure naked plasmid DNA (pDNA) intravascular injections in primate limbs, studying both the distribution of the injected solution in the muscle space, as well as the effects on the vascular system. The distal portion of the four limbs of each of six rhesus monkeys were hydrodynamically injected with naked pDNA, which expressed the luciferase reporter gene. Three-dimensional (3D) T1-weighted gradient echo and 2D multislice T2-weighted fast spin echo (FSE) series were acquired before and immediately after the injection to confirm the volume of solution injected into the limb, and to study the distribution of the injected solution in the individual muscle groups. Time-resolved contrast-enhanced 3D magnetic resonance angiography (MRA) was performed several days before, immediately after, and in a follow-up examination after the pDNA injection to study the effects of the procedure on the primate peripheral vascular system. T1-weighted gradient echo imaging confirmed the delivery of the majority of the solution after successful pDNA injections. T2-weighted FSE imaging demonstrated the distribution of the saline solution in individual muscles in the target limbs, with enhancement showing a weak but significant correlation with the level of gene expression. Time-resolved contrast-enhanced MRA demonstrated effects of the injection procedure on the arterial and venous vascular systems, and the intramuscular compartments; and these effects largely returned to normal on short-term follow-up.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376006     DOI: 10.1089/hum.2006.115

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  7 in total

1.  Evaluation of hydrodynamic limb vein injections in nonhuman primates.

Authors:  Julia O Hegge; Christine I Wooddell; Guofeng Zhang; James E Hagstrom; Serge Braun; Thierry Huss; Magdolna G Sebestyén; Marina E Emborg; Jon A Wolff
Journal:  Hum Gene Ther       Date:  2010-07       Impact factor: 5.695

2.  Dose response in rodents and nonhuman primates after hydrodynamic limb vein delivery of naked plasmid DNA.

Authors:  Christine I Wooddell; Julia O Hegge; Guofeng Zhang; Magdolna G Sebestyén; Mark Noble; Jacob B Griffin; Loretta V Pfannes; Hans Herweijer; James E Hagstrom; Serge Braun; Thierry Huss; Jon A Wolff
Journal:  Hum Gene Ther       Date:  2011-04-18       Impact factor: 5.695

3.  Safety and feasibility of high-pressure transvenous limb perfusion with 0.9% saline in human muscular dystrophy.

Authors:  Zheng Fan; Keith Kocis; Robert Valley; James F Howard; Manisha Chopra; Hongyu An; Weili Lin; Joseph Muenzer; William Powers
Journal:  Mol Ther       Date:  2011-07-19       Impact factor: 11.454

Review 4.  Ultrasound mediated delivery of drugs and genes to solid tumors.

Authors:  Victor Frenkel
Journal:  Adv Drug Deliv Rev       Date:  2008-04-03       Impact factor: 15.470

5.  High-Pressure Transvenous Perfusion of the Upper Extremity in Human Muscular Dystrophy: A Safety Study with 0.9% Saline.

Authors:  Zheng Fan; Keith Kocis; Robert Valley; James F Howard; Manisha Chopra; Yasheng Chen; Hongyu An; Weili Lin; Joseph Muenzer; William Powers
Journal:  Hum Gene Ther       Date:  2015-07-30       Impact factor: 5.695

6.  Hydrostatic isolated limb perfusion with adeno-associated virus vectors enhances correction of skeletal muscle in Pompe disease.

Authors:  B Sun; S Li; A Bird; D D Koeberl
Journal:  Gene Ther       Date:  2010-08-05       Impact factor: 5.250

7.  Development and utility of an internal threshold control (ITC) real-time PCR assay for exogenous DNA detection.

Authors:  Weiyi Ni; Caroline Le Guiner; Philippe Moullier; Richard O Snyder
Journal:  PLoS One       Date:  2012-05-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.